187 related articles for article (PubMed ID: 35752057)
1. NUCB2/nesfatin-1 is associated with severity of eating disorder symptoms in female patients with obesity.
Weibert E; Hofmann T; Elbelt U; Rose M; Stengel A
Psychoneuroendocrinology; 2022 Sep; 143():105842. PubMed ID: 35752057
[TBL] [Abstract][Full Text] [Related]
2. NUCB2/nesfatin-1 Is Associated with Elevated Levels of Anxiety in Anorexia Nervosa.
Hofmann T; Ahnis A; Elbelt U; Rose M; Klapp BF; Stengel A
PLoS One; 2015; 10(7):e0132058. PubMed ID: 26162003
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific regulation of NUCB2/nesfatin-1: Differential implication in anxiety in obese men and women.
Hofmann T; Elbelt U; Ahnis A; Rose M; Klapp BF; Stengel A
Psychoneuroendocrinology; 2015 Oct; 60():130-7. PubMed ID: 26143537
[TBL] [Abstract][Full Text] [Related]
4. NUCB2/nesfatin-1 in the acute stress response of obese women with high and low anxiety.
Schaper SJ; Wölk E; Hofmann T; Friedrich T; Römer M; de Punder K; Rose M; Stengel A
Psychoneuroendocrinology; 2023 Sep; 155():106325. PubMed ID: 37385089
[TBL] [Abstract][Full Text] [Related]
5. Alterations of circulating NUCB2/nesfatin-1 during short term therapeutic improvement of anxiety in obese inpatients.
Hofmann T; Weibert E; Ahnis A; Obbarius A; Elbelt U; Rose M; Klapp BF; Stengel A
Psychoneuroendocrinology; 2017 May; 79():107-115. PubMed ID: 28273586
[TBL] [Abstract][Full Text] [Related]
6. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.
Hofmann T; Stengel A; Ahnis A; Buße P; Elbelt U; Klapp BF
Psychoneuroendocrinology; 2013 Nov; 38(11):2502-10. PubMed ID: 23796625
[TBL] [Abstract][Full Text] [Related]
7. A role of nesfatin-1/NucB2 in dehydration-induced anorexia.
Yoshimura M; Matsuura T; Ohkubo J; Maruyama T; Ishikura T; Hashimoto H; Kakuma T; Mori M; Ueta Y
Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R225-36. PubMed ID: 24829503
[TBL] [Abstract][Full Text] [Related]
8. Does NUCB2/Nesfatin-1 Influence Eating Behaviors in Obese Patients with Binge Eating Disorder? Toward a Neurobiological Pathway.
Caroleo M; Carbone EA; Arcidiacono B; Greco M; Primerano A; Mirabelli M; Fazia G; Rania M; Hribal ML; Gallelli L; Foti DP; De Fazio P; Segura-Garcia C; Brunetti A
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678225
[TBL] [Abstract][Full Text] [Related]
9. Restraint stress affects circulating NUCB2/nesfatin-1 and phoenixin levels in male rats.
Schalla MA; Goebel-Stengel M; Friedrich T; Kühne SG; Kobelt P; Rose M; Stengel A
Psychoneuroendocrinology; 2020 Dec; 122():104906. PubMed ID: 33059202
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice overexpressing nesfatin/nucleobindin-2 are susceptible to high-fat diet-induced obesity.
Shimizu H; Tanaka M; Osaki A
Nutr Diabetes; 2016 Mar; 6(3):e201. PubMed ID: 26950482
[TBL] [Abstract][Full Text] [Related]
11. Activity-based anorexia activates nesfatin-1 immunoreactive neurons in distinct brain nuclei of female rats.
Scharner S; Prinz P; Goebel-Stengel M; Lommel R; Kobelt P; Hofmann T; Rose M; Stengel A
Brain Res; 2017 Dec; 1677():33-46. PubMed ID: 28951234
[TBL] [Abstract][Full Text] [Related]
12. Role of brain NUCB2/nesfatin-1 in stress and stress-related gastrointestinal disorders.
Zheng J; Han J; Wang Y; Tian Z
Peptides; 2023 Sep; 167():171043. PubMed ID: 37311488
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide increases gastric and circulating NUCB2/nesfatin-1 concentrations in rats.
Stengel A; Goebel-Stengel M; Jawien J; Kobelt P; Taché Y; Lambrecht NW
Peptides; 2011 Sep; 32(9):1942-7. PubMed ID: 21782869
[TBL] [Abstract][Full Text] [Related]
14. Role of brain NUCB2/nesfatin-1 in the regulation of food intake.
Stengel A; Taché Y
Curr Pharm Des; 2013; 19(39):6955-9. PubMed ID: 23537088
[TBL] [Abstract][Full Text] [Related]
15. Expression of gastrointestinal nesfatin-1 and gastric emptying in ventromedial hypothalamic nucleus- and ventrolateral hypothalamic nucleus-lesioned rats.
Tian ZB; Deng RJ; Sun GR; Wei LZ; Kong XJ; Ding XL; Jing X; Zhang CP; Ge YL
World J Gastroenterol; 2014 Jun; 20(22):6897-905. PubMed ID: 24944480
[TBL] [Abstract][Full Text] [Related]
16. Activation of central nesfatin-1/NucB2 after intraperitoneally administered cisplatin in rats.
Akiyama Y; Yoshimura M; Nishimura K; Nishimura H; Sonoda S; Ueno H; Mitojima Y; Saito R; Maruyama T; Nonaka Y; Hashimoto H; Uezono Y; Hirata K; Ueta Y
Biochem Biophys Res Commun; 2017 Aug; 490(3):794-799. PubMed ID: 28645611
[TBL] [Abstract][Full Text] [Related]
17. The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.
Stengel A; Mori M; Taché Y
Obes Rev; 2013 Nov; 14(11):859-70. PubMed ID: 23980879
[TBL] [Abstract][Full Text] [Related]
18. Nucleobindin-2/Nesfatin-1 in the Human Hypothalamus Is Reduced in Obese Subjects and Colocalizes with Oxytocin, Vasopressin, Melanin-Concentrating Hormone, and Cocaine- and Amphetamine-Regulated Transcript.
Psilopanagioti A; Nikou S; Papadaki H
Neuroendocrinology; 2019; 108(3):190-200. PubMed ID: 30625474
[TBL] [Abstract][Full Text] [Related]
19. Nesfatin-1: a novel inhibitory regulator of food intake and body weight.
Stengel A; Goebel M; Taché Y
Obes Rev; 2011 Apr; 12(4):261-71. PubMed ID: 20546141
[TBL] [Abstract][Full Text] [Related]
20. Nesfatin-1 - More than a food intake regulatory peptide.
Stengel A
Peptides; 2015 Oct; 72():175-83. PubMed ID: 26116783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
